Vireo Growth (VREOF) Debt to Equity (2020 - 2026)

Vireo Growth's (VREOF) quarterly Debt to Equity came in at $0.68 in Q1 2026, down 45.53% year-on-year from $1.24 in Q1 2025, and up 44.25% quarter-over-quarter from $0.47 in Q4 2025.

Vireo Growth (VREOF) Debt to Equity (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Debt to Equity across 7 years of filings, most recently posting $0.68 for Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.68, down 45.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.68 (down 45.53% YoY), and the FY2025 annual result was $0.47, down 58.82% from the prior year.
  • Debt to Equity came in at $0.68 for Q1 2026 at Vireo Growth, up from $0.47 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $16.86 in Q4 2022 to a low of -$28.15 in Q1 2023.
  • The 5-year median for Debt to Equity is $0.47 (2025), against an average of -$1.8.
  • Across the five-year window, Debt to Equity jumped 2553.76% in 2022 and tumbled 2723.03% in 2023, its largest moves.
  • Vireo Growth's Debt to Equity stood at $16.86 in 2022, then plunged by 144.51% to -$7.51 in 2023, then soared by 115.14% to $1.14 in 2024, then plunged by 58.82% to $0.47 in 2025, then jumped by 44.25% to $0.68 in 2026.
  • The last three Debt to Equity figures came in at $0.68 (Q1 2026), $0.47 (Q4 2025), and $0.54 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 2.02
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 2.80
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.61
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.86
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.47
10 Vireo Growth - - 59.30 Mn 0.68

Historic Data

Download Data
DateValue
Mar 31, 2026 0.68
Dec 31, 2025 0.47
Sep 30, 2025 0.54
Jun 30, 2025 0.40
Mar 31, 2025 1.24
Dec 31, 2024 1.14
Sep 30, 2024 -5.27
Jun 30, 2024 -2.78
Mar 31, 2024 -2.70
Dec 31, 2023 -7.51
Sep 30, 2023 -4.63
Jun 30, 2023 -7.29
Mar 31, 2023 -28.15
Dec 31, 2022 16.86
Sep 30, 2022 3.38
Jun 30, 2022 1.91
Mar 31, 2022 1.07
Dec 31, 2021 0.64
Sep 30, 2021 0.38
Jun 30, 2021 0.33